Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 88 publications
2025 International Academy of Toxicologic Pathology (IATP) Satellite Symposium: Pathology Working Groups (PWGs) in Toxicologic Pathology.
Journal: Toxicologic pathology
Published: June 23, 2026
Carcinogenicity Risk Assessment of Agrochemicals and Pharmaceuticals.
Journal: Toxicologic pathology
Published: April 05, 2026
Integrated long-term safety of 10-year ozanimod treatment: results from clinical trials in patients with moderate-to-severe ulcerative colitis or relapsing multiple sclerosis.
Journal: Inflammatory bowel diseases
Published: August 27, 2025
Enhancing pesticide risk assessment processes at the US Environmental Protection Agency.
Journal: Regulatory toxicology and pharmacology : RTP
Published: August 22, 2025
Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn's Disease.
Journal: Inflammatory bowel diseases
Published: March 03, 2025
Transforming the Evaluation of Agrochemicals: A Conceptual Model.
Journal: Regulatory toxicology and pharmacology : RTP
Published: January 24, 2025
Impact of Prior Biologic Exposure on Ozanimod Efficacy and Safety in the Phase 3 True North Clinical Trial.
Journal: The American journal of gastroenterology
Published: August 08, 2024
Wound Healing After Vaginal Delivery, Episiotomy, and Cesarean Section Delivery Among Women With IBD: Results From the PIANO Registry.
Journal: Inflammatory bowel diseases
Published: August 07, 2024
Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials.
Journal: Journal of Crohn's & colitis
Published: June 15, 2024
A Novel Approach to Integrate Human Biomonitoring Data with Model Predicted Dietary Exposures: A Crop Protection Chemical Case Study Using Lambda-Cyhalothrin.
Journal: Journal of agricultural and food chemistry
Published: May 08, 2024
Assessing human carcinogenicity risk of agrochemicals without the rodent cancer bioassay.
Journal: Frontiers in toxicology
Published: March 01, 2024
Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with Moderately to Severely Active Crohn's Disease.
Journal: Digestive diseases and sciences
Published: December 05, 2023
Last Updated: 09/26/2026